CBD Gummies and THC Limits: Why Legal Labels Can Be Confusing

CBD Gummies and THC Limits: Why Legal Labels Can Be Confusing

If you've shopped for CBD gummies and tried to make sense of the THC content claims on labels, you've probably encountered a confusing patchwork of numbers, percentages, and terminology that doesn't quite add up. "0.3% THC," "THC-free," "non-detect," "broad-spectrum," "full-spectrum" — these terms appear on labels throughout the hemp CBD market, often without explanation, and they don't always mean what consumers assume they do. This article breaks down the regulatory framework behind THC labeling in hemp products, explains why the 0.3% limit is less straightforward than it appears, and gives you the tools to read labels more critically.

Where the 0.3% THC Limit Comes From

The 0.3% THC threshold that defines legal hemp in the United States was established by the 2018 Farm Bill (Agriculture Improvement Act of 2018). Under this law, hemp is defined as cannabis sativa containing no more than 0.3% delta-9 THC on a dry weight basis. Cannabis exceeding this threshold is classified as marijuana and regulated under the Controlled Substances Act. This single number — 0.3% — is the legal dividing line between an agricultural commodity and a Schedule I controlled substance.

The 0.3% figure itself was not derived from pharmacological research on psychoactive thresholds — it originated in a 1976 botanical paper by Canadian plant researchers Ernest Small and Arthur Cronquist who proposed it as a taxonomic distinction between hemp and drug-type cannabis. It was later adopted as a regulatory threshold, first in Canada and then in US law, not because 0.3% was determined to be the precise cutoff for psychoactivity, but because it represented a reasonable line of demarcation between industrial hemp cultivation and drug plant cultivation. [PMID 28645601]

Understanding the origin of this number matters because it explains something important: the 0.3% limit is a legal definition, not a safety or psychoactivity standard. It tells you whether a plant is legally classified as hemp or marijuana under US federal law. It does not directly tell you whether a finished consumer product will cause intoxication, fail a drug test, or affect you pharmacologically.

The "Dry Weight Basis" Problem

The 0.3% limit applies to the raw hemp plant "on a dry weight basis." This is straightforward when testing agricultural hemp crops. It becomes far more complicated when applied to concentrated hemp extracts, finished products like gummies, or oil-based formulations.

When hemp is processed into concentrated extract, the cannabinoid concentrations increase substantially — that's the entire point of extraction. A hemp plant with 10% CBD and 0.3% THC (a 33:1 CBD:THC ratio) produces an extract that may contain 60–80% CBD and proportionally concentrated THC. The 0.3% threshold that applied to the raw plant no longer cleanly applies to the concentrated extract in the same way. A full-spectrum extract could technically contain more THC by percentage than the raw plant limit while still being derived from compliant hemp.

For finished consumer products like CBD gummies, the relevant question shifts from "what percentage of the raw plant was THC" to "how many milligrams of THC are in this serving." A gummy with 25 mg of total cannabinoids and 0.5 mg of THC contains 2% THC by mass of cannabinoids — well above 0.3% on that basis — but the total product weight (including sugars, gelatin, flavoring, etc.) might dilute the percentage down well below 0.3%. The math depends entirely on what denominator you use, and the law doesn't specify the denominator for finished consumer products in the way it does for raw hemp plants. [PMID 33516280]

Delta-9 THC vs. Total THC: A Critical Distinction

The 2018 Farm Bill's 0.3% limit specifically applies to delta-9 THC — the primary psychoactive form of THC. However, hemp also contains THCA (tetrahydrocannabinolic acid), which is the non-psychoactive precursor to delta-9 THC. When cannabis is heated (smoked, vaped, or cooked), THCA converts to delta-9 THC through a process called decarboxylation.

This creates a regulatory gap. A hemp plant or extract could have low delta-9 THC (below 0.3%) but high THCA, and that THCA can convert to delta-9 THC during processing — particularly during the heating steps involved in making gummies or other edibles. The USDA has moved toward requiring total THC (delta-9 THC + THCA × 0.877) for agricultural compliance testing, recognizing that THCA-rich hemp can produce delta-9 THC-rich products through normal processing. But the regulations and enforcement of this distinction remain inconsistent across states and agencies. [PMID 34836619]

For consumers, this matters because a product label showing delta-9 THC only might look compliant while the total THC (including THCA that could convert to delta-9) is substantially higher. Certificate of Analysis (COA) panels that include THCA alongside delta-9 THC give a more complete picture. Products that show delta-9 THC alone without reporting THCA are providing incomplete cannabinoid information.

What Labels Say vs. What They Mean

Hemp CBD product labels use a range of THC-related claims that carry different meanings — and different levels of regulatory backing:

"Contains less than 0.3% THC": This is a compliance statement referencing the federal hemp definition. It tells you the product was derived from compliant hemp but says little about the actual milligram amount of THC per serving or how that was measured. A product with 0.29% THC by weight could still contain meaningful per-serving THC depending on the serving size and total product weight.

"THC-Free": This claim is not defined or regulated by the FDA for hemp products. Manufacturers use it inconsistently — some mean non-detect on a third-party COA, others mean below 0.01%, and some simply mean broad-spectrum extraction was used (which removes most but not necessarily all THC). Without a COA showing the specific LOD (limit of detection) of the testing method, "THC-free" is a marketing claim, not a verified fact. The FDA has warned that "THC-free" claims on CBD products can be misleading. [PMID 35366580]

"Non-Detect" (ND) on a COA: This is more meaningful than "THC-free" on a label because it references a specific analytical result. However, "non-detect" means THC was not found above the method's limit of detection — which varies by laboratory. A method with an LOD of 10 ppm will call a product "ND" if it contains 9 ppm of THC. That's not zero; it's below the detection threshold. Consumers who need true zero THC should look for COAs that specify the LOD and understand that ND means "below X" rather than literally zero. Quality CBD gummies from reputable manufacturers disclose this distinction.

"Broad-Spectrum": This term implies THC has been removed while other cannabinoids were retained. As discussed in other articles in this series, there is no FDA definition of "broad-spectrum," and products carrying this label can range from genuinely THC-free isolate blends to full-spectrum extracts with only modest THC reduction. The only way to verify what "broad-spectrum" actually means for a specific product is to examine the COA.

"Full-Spectrum": Means THC is present in the product, retained from the original hemp plant material. This is the most honest and least ambiguous label in terms of THC presence — a product calling itself full-spectrum is telling you THC is there. The amount should be confirmed via COA, but at minimum the label is not misleading about THC presence.

The State-Level Layer of Complexity

Federal law sets a floor for hemp THC limits, but states can be more restrictive — and many are. The regulatory landscape for hemp-derived CBD products varies significantly by state, creating a patchwork that confuses both manufacturers and consumers.

Some states have adopted the federal 0.3% delta-9 THC standard for finished products. Others apply the limit to total THC (delta-9 plus THCA). A few states have set lower thresholds than 0.3% for finished consumer products. Several states have additional labeling requirements — mandatory THC content disclosure in milligrams, COA availability requirements, or age-gating requirements — that go beyond federal law. And some states have specific restrictions on the forms in which hemp CBD can legally be sold (a handful have restricted edibles entirely at various points).

This means a product that is fully legal in one state may not be in another, and a label that satisfies federal requirements may not satisfy the state where you purchased it. The "compliant" claim on a label almost always refers to federal hemp law compliance — it may or may not account for your state's specific rules.

The Hemp-Derived Delta-9 Edibles Phenomenon

One of the most confusing developments in the hemp marketplace in recent years has been the emergence of products specifically engineered to contain significant amounts of delta-9 THC while technically remaining below the 0.3% threshold by exploiting the dry weight calculation.

Here's how the math works: if a gummy weighs 4.5 grams total (4,500 mg), then 0.3% of 4,500 mg is 13.5 mg of delta-9 THC. A heavy gummy with sufficient filler ingredients can contain 10 mg of delta-9 THC and still be technically "below 0.3% by dry weight" of the finished product. These products are sold openly, labeled as hemp-derived, and marketed with language like "federally legal" or "Farm Bill compliant."

These hemp-derived delta-9 edibles are categorically different from the CBD gummies this article series addresses. A hemp-derived delta-9 gummy with 10 mg THC is a product designed to produce intoxication — it is pharmacologically equivalent to a marijuana edible. The fact that it's "legal hemp" under a technical reading of the dry weight calculation doesn't change its pharmacological reality. Consumers shopping for CBD wellness products who accidentally purchase hemp-derived delta-9 edibles are in for a very different experience than expected. [PMID 36455407]

The proliferation of these products is a primary reason why reading labels carefully and checking COAs has become essential for anyone buying hemp-derived edibles. The category now includes everything from non-intoxicating CBD wellness supplements to products specifically engineered to produce a high, all sold in similar-looking packaging with similar legal compliance language.

Novel Cannabinoids and the Label Gap

The labeling confusion extends beyond delta-9 THC to a growing family of hemp-derived cannabinoids that occupy regulatory gray areas. Delta-8 THC, delta-10 THC, HHC (hexahydrocannabinol), THCO (THC acetate), and THCp are among the cannabinoids now commonly found in hemp marketplace products. Most of these are produced by converting CBD or other hemp cannabinoids through chemical synthesis — they are not naturally occurring in hemp in meaningful quantities.

The 2018 Farm Bill's 0.3% limit references delta-9 THC specifically, and many of these novel cannabinoids are psychoactive while not being delta-9 THC. Their legal status is contested and varies by state — the DEA has taken the position that synthetically derived THC isomers remain Schedule I regardless of hemp origin, while some courts and state regulators have reached different conclusions. Products containing these cannabinoids may be labeled without clearly disclosing their psychoactive potential, and consumers looking for non-intoxicating CBD gummies can inadvertently purchase something quite different.

Standard hemp CBD gummies from established manufacturers don't contain delta-8, HHC, or other novel psychoactive cannabinoids — but the hemp marketplace has expanded to include many products that do, often without clear labeling. A COA that tests only for delta-9 THC won't reveal the presence of these compounds.

How to Read a Label and COA for THC Information

Given the complexity described above, here's a practical framework for evaluating THC claims on hemp CBD products:

Step 1 — Find the COA, not just the label. The label claim is marketing; the COA is the verified analytical result. Every legitimate hemp CBD product should have a batch-specific COA from an accredited third-party laboratory available on the company website or via QR code. If it's not available, treat the label claims skeptically.

Step 2 — Look for both delta-9 THC and THCA. A comprehensive COA reports delta-9 THC and THCA separately, along with the calculated total THC. If only delta-9 is reported and THCA is absent, the panel may be incomplete. Total THC = delta-9 THC + (THCA × 0.877).

Step 3 — Note the units and serving context. Look at whether THC is reported as a percentage of the total product or as milligrams per serving/per unit. Milligrams per serving is what matters pharmacologically. Convert percentage to milligrams if needed: 0.1% of a 3,000 mg (3 gram) gummy = 3 mg of THC per gummy.

Step 4 — Check the LOD and LOQ for "ND" results. If the COA shows delta-9 THC as "ND" (non-detect), look for the method's limit of detection. A well-documented COA specifies LOD and LOQ. If these aren't listed, the ND result is less informative than it appears.

Step 5 — Verify the cannabinoid panel is complete. For premium CBD gummies where the label says broad-spectrum, look for the presence of minor cannabinoids (CBG, CBN, CBC, etc.) confirming that other cannabinoids were retained while THC was removed. An isolate-based product won't show these; a true broad-spectrum product should.

Step 6 — Match the COA batch to the product. The COA should reference the same batch number (lot number) printed on the product packaging. A COA from a different batch or with no batch reference doesn't verify the product you're holding.

Why Labeling Reform Hasn't Happened

The FDA has authority to regulate hemp-derived CBD products as dietary supplements or food additives but has not yet issued comprehensive labeling regulations for the hemp CBD industry. The agency has acknowledged receiving thousands of public comments and has conducted market research, but as of 2025 has not published binding labeling standards for CBD content, THC limits in finished products, or standardized terminology like "broad-spectrum" and "THC-free."

This regulatory gap means that the hemp CBD marketplace operates largely on voluntary compliance with industry best practices, third-party certification programs, and state-level regulations. The result is the labeling inconsistency consumers encounter: similar products with wildly different levels of transparency, different terminology for similar formulations, and claims that range from precise and verifiable to vague and effectively meaningless.

Until federal labeling standards are in place, consumer due diligence — specifically the COA-reading skills described in this series — remains the most reliable protection against purchasing a product that doesn't deliver what its label suggests. [PMID 33516280]

What PureCraft's Labeling Approach Means in Practice

PureCraft CBD gummies use broad-spectrum hemp extract processed to remove THC to non-detect levels on batch-specific third-party COAs. The COAs are published and batch-matched, allowing verification against specific lot numbers. The cannabinoid panels include both delta-9 THC and THCA, and the test methods specify detection limits so that "non-detect" has a defined meaning rather than being a vague claim.

This approach reflects the kind of transparency that the labeling confusion in the hemp market makes valuable. Rather than relying on label claims alone, consumers can verify exactly what is — and isn't — in each batch. In a marketplace where "THC-free" can mean anything from genuinely non-detect to simply lower-than-average, batch-verified COAs convert a label claim into an auditable fact.

Summary

The 0.3% THC limit in US hemp law is a legal definition derived from a botanical taxonomy paper, not a pharmacological threshold — and its application to finished consumer products is considerably more complicated than the simple number suggests. "Dry weight basis" calculations, the delta-9 vs. total THC distinction, the lack of FDA definitions for terms like "broad-spectrum" and "THC-free," the emergence of hemp-derived high-THC edibles that technically comply with the Farm Bill, and the proliferation of novel psychoactive cannabinoids have combined to create a labeling environment where similar-looking products can be radically different in their actual THC content and pharmacological effects.

For consumers buying CBD gummies for wellness purposes — not intoxication — the practical response is to treat label claims as a starting point and batch-specific COAs as the verification. The framework described in this article gives you the tools to interpret what you're reading and ask the right questions about the products you're considering.

Disclaimer: This article is for informational purposes only and does not constitute legal or medical advice. Hemp and CBD regulations change frequently and vary by state. Always verify current rules in your jurisdiction and consult a healthcare provider with specific health questions.